These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33316454)

  • 1. The Glucocorticoid Receptor in Intestinal Epithelial Cells Alleviates Colitis and Associated Colorectal Cancer in Mice.
    Muzzi C; Watanabe N; Twomey E; Meers GK; Reichardt HM; Bohnenberger H; Reichardt SD
    Cell Mol Gastroenterol Hepatol; 2021; 11(5):1505-1518. PubMed ID: 33316454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
    Srivatsa S; Paul MC; Cardone C; Holcmann M; Amberg N; Pathria P; Diamanti MA; Linder M; Timelthaler G; Dienes HP; Kenner L; Wrba F; Prager GW; Rose-John S; Eferl R; Liguori G; Botti G; Martinelli E; Greten FR; Ciardiello F; Sibilia M
    Gastroenterology; 2017 Jul; 153(1):178-190.e10. PubMed ID: 28400195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL11 exacerbates colitis and inflammation-associated colon tumorigenesis.
    Polosukhina D; Singh K; Asim M; Barry DP; Allaman MM; Hardbower DM; Piazuelo MB; Washington MK; Gobert AP; Wilson KT; Coburn LA
    Oncogene; 2021 Nov; 40(47):6540-6546. PubMed ID: 34625710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
    Burgueño JF; Fritsch J; González EE; Landau KS; Santander AM; Fernández I; Hazime H; Davies JM; Santaolalla R; Phillips MC; Diaz S; Dheer R; Brito N; Pignac-Kobinger J; Fernández E; Conner GE; Abreu MT
    Gastroenterology; 2021 Feb; 160(3):797-808.e6. PubMed ID: 33127391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockout of Factor-Inhibiting HIF (
    Schützhold V; Gravemeyer J; Bicker A; Hager T; Padberg C; Schäfer J; Wrobeln A; Steinbrink M; Zeynel S; Hankeln T; Becker JC; Fandrey J; Winning S
    J Immunol; 2022 Mar; 208(5):1280-1291. PubMed ID: 35121641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models.
    Marie MA; Sanderlin EJ; Satturwar S; Hong H; Lertpiriyapong K; Donthi D; Yang LV
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166288. PubMed ID: 34628032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in Mice.
    Lavoie S; Chun E; Bae S; Brennan CA; Gallini Comeau CA; Lang JK; Michaud M; Hoveyda HR; Fraser GL; Fuller MH; Layden BT; Glickman JN; Garrett WS
    Gastroenterology; 2020 Apr; 158(5):1359-1372.e9. PubMed ID: 31917258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
    Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
    Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice carrying an epithelial deletion of the glucocorticoid receptor NR3C1 develop a higher tumor load in experimental colitis-associated cancer.
    Arredondo-Amador M; González R; Aranda CJ; Martínez-Augustin O; Sánchez de Medina F
    Am J Physiol Gastrointest Liver Physiol; 2021 Dec; 321(6):G705-G718. PubMed ID: 34669484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression.
    Kotelevets L; Walker F; Mamadou G; Lehy T; Jordan P; Chastre E
    Oncogene; 2018 Nov; 37(46):6054-6068. PubMed ID: 29985482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial vanin-1 controls inflammation-driven carcinogenesis in the colitis-associated colon cancer model.
    Pouyet L; Roisin-Bouffay C; Clément A; Millet V; Garcia S; Chasson L; Issaly N; Rostan A; Hofman P; Naquet P; Galland F
    Inflamm Bowel Dis; 2010 Jan; 16(1):96-104. PubMed ID: 19572375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis.
    Xu P; Xi Y; Zhu J; Zhang M; Luka Z; Stolz DB; Cai X; Xie Y; Xu M; Ren S; Huang Z; Yang D; York JD; Ma X; Xie W
    Gastroenterology; 2021 Jul; 161(1):271-286.e11. PubMed ID: 33819483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
    Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer.
    Short SP; Pilat JM; Barrett CW; Reddy VK; Haberman Y; Hendren JR; Marsh BJ; Keating CE; Motley AK; Hill KE; Zemper AE; Washington MK; Shi C; Chen X; Wilson KT; Hyams JS; Denson LA; Burk RF; Rosen MJ; Williams CS
    Gastroenterology; 2021 Apr; 160(5):1694-1708.e3. PubMed ID: 33388316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent hypoxia promotes carcinogenesis in azoxymethane and dextran sodium sulfate-induced colon cancer model.
    Yoon DW; Kim YS; Hwang S; Khalmuratova R; Lee M; Kim JH; Lee GY; Koh SJ; Park JW; Shin HW
    Mol Carcinog; 2019 May; 58(5):654-665. PubMed ID: 30575123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of polarity protein Par3 in the intestinal epithelium promotes colitis-associated colorectal cancer progression by damaging tight junction assembly.
    Luo B; Song L; Chen L; Cai Y; Zhang M; Wang S
    Mol Carcinog; 2023 Dec; 62(12):1990-2004. PubMed ID: 37702006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis.
    Miyazaki T; Shirakami Y; Mizutani T; Maruta A; Ideta T; Kubota M; Sakai H; Ibuka T; Genovese S; Fiorito S; Taddeo VA; Epifano F; Tanaka T; Shimizu M
    Sci Rep; 2021 Jan; 11(1):492. PubMed ID: 33436792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cldn-7 deficiency promotes experimental colitis and associated carcinogenesis by regulating intestinal epithelial integrity.
    Wang K; Ding Y; Xu C; Hao M; Li H; Ding L
    Oncoimmunology; 2021 May; 10(1):1923910. PubMed ID: 34026335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy.
    Sheng YH; Giri R; Davies J; Schreiber V; Alabbas S; Movva R; He Y; Wu A; Hooper J; McWhinney B; Oancea I; Kijanka G; Hasnain S; Lucke AJ; Fairlie DP; McGuckin MA; Florin TH; Begun J
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):33-53. PubMed ID: 32497793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.